Primary hypobetalipoproteinemia (HBL) can be either monogenic or polygenic.

We compared two polygenic risk scores (PRS1-PRS2) in primary HBL.

Among 170 subjects with primary HBL, 37% had a polygenic origin.

Prevalence of liver steatosis did not differ in monogenic and polygenic HBL.

Only PRS1 is effective in detecting polygenic HBL.

Primary Hypobetalipoproteinemias (HBL) are a group of dominant and recessive monogenic genetic disorders caused by mutations in APOB, PCSK9, ANGPTL3, MTTP, Sar1b genes and characterized by plasma levels of total cholesterol (TC), low density lipoprotein-cholesterol (LDL-C) and apolipoprotein B (apoB) below the 5th percentile of the distribution in a given population. Mutations in the candidate genes account only for a small proportion of subjects with HBL suggesting a role for a polygenic contribution to the low cholesterol phenotype.

To explore the complex genetic architecture of HBL we compared two polygenic risk scores in order to assess the role of the polygenic burden and the differences in the clinical phenotype between monogenic and polygenic HBL; we studied a cohort of 170 subjects with primary HBL referred over a 25-year period to 2 Italian reference centers have been studied.

The genetic analyses have been based on: Sanger sequencing, in-house NGS customized panel and two scores, PRS1 and PRS2 for the polygenic burden.

Sixty 60 (35%) and 63 (37%) subjects had a monogenic and polygenic HBL respectively. LDL-C plasma levels were significantly lower in monogenic HBL (30.87 ± 3.12 mg/dl) compared with the non-monogenic HBL (42.80 ± 2.18 mg/dl) (p<0.002) with no differences in the percentage of fatty liver.

Only PRS1 is effective in detecting polygenic HBL while PRS2 does not improve the polygenic diagnosis.

Hypobetalipoproteinemia

Mutations

Polygenic risk score

Panel based NGS sequencing

© 2022 National Lipid Association. Published by Elsevier Inc. All rights reserved.